Skip to main content

Profiles

Pfizer-BioNTech COVID-19 vaccine clinical trial

The Pfizer-BioNTech COVID-19 vaccine candidates were tested in a three-phase clinical trial in 2020, registered on ClinicalTrials.gov with identifying number C4591001.[1]

Investigators

The list of investigators was published as a Supplementary Appendix.[2]

Trial sites

There were 169 official clinical trial sites listed on the trial's ClinicalTrials.gov listing.[1:1] Organizations that served as clinical trial sites included:

  • Acevedo Clinical Research Associates
  • AMR Mobile
  • Anaheim Clinical Trials (ACT)
  • Bayview Research Group (BRG)
  • California Research Foundation (CRF)
  • Chinle Comprehensive Health Care Facility
  • Clinical and Translational Science Center (CTSC)
  • Clinical Research Consortium (CRC)
  • Clinical Research Consulting (CRC)
  • Clinical Research of South Florida
  • CNS Healthcare
  • Collaborative Neuroscience Research (CNS)
  • DeLand Clinical Research Unit
  • Diablo Clinical Research
  • Fleming Island Center for Clinical Research
  • Hope Research Institute
  • Indago Research and Health Center
  • Jacksonville Center for Clinical Research
  • Johns Hopkins Center for American Indian Health
  • Kaiser Permanente Los Angeles Medical Center
  • Kaiser Permanente Northern California
  • Kaiser Permanente Santa Clara
  • Long Beach Clinical Trials
  • Lynn Institute of Denver
  • Medical Affiliated Research Center
  • National Research Institute
  • North Alabama Research Center
  • The Pain Center of Arizona
  • Paradigm Clinical Research
  • Providence Clinical Research
  • Research Centers of America
  • UC Davis Medical Center
  • Whiteriver Indian Hospital
  • Yale Center for Clinical Investigation

  1. BioNTech SE, & Pfizer. (2023, February 28). Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov. https://web.archive.org/web/20230420203001/https://clinicaltrials.gov/ct2/show/NCT04368728 ↩︎ ↩︎

  2. Supplementary Appendix (p. 2). (2021). medRxiv. https://web.archive.org/web/20230826041437/https://www.medrxiv.org/content/medrxiv/early/2021/07/28/2021.07.28.21261159/DC1/embed/media-1.pdf ↩︎